JP2020530300A5 - - Google Patents

Download PDF

Info

Publication number
JP2020530300A5
JP2020530300A5 JP2020507589A JP2020507589A JP2020530300A5 JP 2020530300 A5 JP2020530300 A5 JP 2020530300A5 JP 2020507589 A JP2020507589 A JP 2020507589A JP 2020507589 A JP2020507589 A JP 2020507589A JP 2020530300 A5 JP2020530300 A5 JP 2020530300A5
Authority
JP
Japan
Prior art keywords
gpa
variant
cleaved
seq
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020507589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530300A (ja
JP7744621B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/046196 external-priority patent/WO2019032952A1/en
Publication of JP2020530300A publication Critical patent/JP2020530300A/ja
Publication of JP2020530300A5 publication Critical patent/JP2020530300A5/ja
Application granted granted Critical
Publication of JP7744621B2 publication Critical patent/JP7744621B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020507589A 2017-08-11 2018-08-10 切断されたモルモットｌ－アスパラギナーゼバリアントおよび使用の方法 Active JP7744621B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762544411P 2017-08-11 2017-08-11
US201762544396P 2017-08-11 2017-08-11
US62/544,396 2017-08-11
US62/544,411 2017-08-11
PCT/US2018/046196 WO2019032952A1 (en) 2017-08-11 2018-08-10 TRUNCATED VARIANTS OF INDIA PIG ASPARAGINASE AND METHODS OF USE

Publications (3)

Publication Number Publication Date
JP2020530300A JP2020530300A (ja) 2020-10-22
JP2020530300A5 true JP2020530300A5 (https=) 2021-09-24
JP7744621B2 JP7744621B2 (ja) 2025-09-26

Family

ID=63405429

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020507589A Active JP7744621B2 (ja) 2017-08-11 2018-08-10 切断されたモルモットｌ－アスパラギナーゼバリアントおよび使用の方法

Country Status (8)

Country Link
US (1) US11578315B2 (https=)
EP (1) EP3664832B1 (https=)
JP (1) JP7744621B2 (https=)
CN (1) CN111050784B (https=)
AU (1) AU2018313253B2 (https=)
CA (1) CA3106549A1 (https=)
ES (1) ES2965372T3 (https=)
WO (1) WO2019032952A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114292853A (zh) * 2021-11-29 2022-04-08 国药集团动物保健股份有限公司 Sumo促溶表达标签及其应用、sumo促溶表达蛋白、重组菌株及蛋白的制备方法
CN114369173B (zh) * 2022-03-22 2022-07-08 中国农业科学院北京畜牧兽医研究所 一种利用融合蛋白标签促进人颗粒溶素及动物NK lysin在毕赤酵母中表达的方法
CN116459344B (zh) * 2023-04-28 2025-03-18 上海市生物医药技术研究院 一种MNSFβ/RC3H1 PPI干扰多肽的抗炎治疗应用
WO2025026424A1 (en) * 2023-08-02 2025-02-06 The Hong Kong Polytechnic University Bioengineered asparaginase fusion proteins
WO2025210068A1 (en) 2024-04-03 2025-10-09 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Activity-improved variants of human asparaginase 1

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US6267964B1 (en) 1989-08-01 2001-07-31 Affibody Technology Sweden Ab Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives
SE9002213D0 (sv) 1990-06-21 1990-06-21 Hightech Receptor Ab Albumin binding proteins
US5766897A (en) 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US6565841B1 (en) 1991-03-15 2003-05-20 Amgen, Inc. Pulmonary administration of granulocyte colony stimulating factor
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
JP3721210B2 (ja) * 1995-02-08 2005-11-30 株式会社林原生物化学研究所 哺乳類のｌ−アスパラギナーゼをコードするｄｎａ
US6537547B1 (en) * 1996-06-07 2003-03-25 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Polypeptides having L-asparaginase activity
JP3819540B2 (ja) * 1996-06-07 2006-09-13 株式会社林原生物化学研究所 Ｌ−アスパラギナーゼ活性を有する哺乳類由来のポリペプチド
EP2180054A1 (en) 1999-12-24 2010-04-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20050287153A1 (en) 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
US20040001827A1 (en) 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US20020065397A1 (en) 2000-10-12 2002-05-30 Joseph Roberts Protecting therapeutic compositions from host-mediated inactivation
WO2004112717A2 (en) * 2003-06-17 2004-12-29 Harrison Roger G Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
AU2004254600A1 (en) 2003-06-26 2005-01-13 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
JP5634008B2 (ja) 2004-04-06 2014-12-03 アフィボディ・アーベー 新規の使用および方法
US7985548B2 (en) 2006-03-03 2011-07-26 The United States Of America As Represented By The Department Of Health And Human Services Materials and methods directed to asparagine synthetase and asparaginase therapies
EP1894940A1 (en) * 2006-08-28 2008-03-05 Apogenix GmbH TNF superfamily fusion proteins
WO2009002947A2 (en) 2007-06-22 2008-12-31 Affymax, Inc. Compounds and peptides that bind the trail receptor
BR112012003346A2 (pt) * 2009-08-15 2016-11-16 Genentech Inc metodo de tratamento de um paciente diagnostico com cancer de mama metastico previamente tratado kit para tratamento de cancer de mama metastatico previamente tratado em um paciente humano metodo para instruir um paciente humano com cancer metodo promocional e metodo comercial
WO2012075173A2 (en) * 2010-12-01 2012-06-07 Board Of Regents The University Of Texas System Compositions and method for deimmunization of proteins
WO2012170640A1 (en) 2011-06-07 2012-12-13 The Trustees Of Columbia University In The City Of New York Methods and compositions for trail-drug combination therapy
CA2849705A1 (en) 2011-09-23 2013-03-28 Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Modified albumin-binding domains and uses thereof to improve pharmacokinetics
CN103184209B (zh) * 2011-12-27 2015-09-16 拜奥生物科技（上海）有限公司 人精氨酸酶和聚乙二醇化人精氨酸酶及其应用
MX355041B (es) 2012-05-25 2018-03-28 Janssen Biotech Inc Dominios de union a albumina consenso no naturales.
NO2776305T3 (https=) * 2014-04-23 2018-01-27

Similar Documents

Publication Publication Date Title
JP2020530300A5 (https=)
JP2019509041A5 (https=)
JP2021521822A5 (https=)
SA521430398B1 (ar) Ph20 تركيبة صيدلانية، تشمل متغير ودواء هيالورونيداز البشرى، للحقن تحت الجلد
FI3715367T3 (fi) Il-2-proteiinia ja cd80-proteiinia sisältävä fuusioproteiini ja sen käyttö
JP2023144018A5 (https=)
JP2017018125A5 (https=)
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
JP2019536462A5 (https=)
JP2018522563A5 (https=)
HRP20230150T1 (hr) Konstrukcija kimernog antigenskog receptora koji cilja cd20 antigen i identifikacija aktivnosti njegovih inženjerskih t-stanica
MY204458A (en) Tertiary amino lipidated cationic peptides for nucleic acid delivery
JP2019525753A5 (https=)
JP2004511201A5 (https=)
BRPI0511118A (pt) polipeptìdeos de haemophilus influenzae não transcritos
JP2017537627A5 (https=)
NZ587105A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
JP2008514618A5 (https=)
WO2022256500A3 (en) Dll3 targeting trispecific proteins and methods of use
KR20150124999A (ko) 암 표적화 치료용 알부민-결합 아르기닌 데이미나제를 포함하는 약제학적 조성물
JP2013172743A5 (https=)
MX2009008118A (es) Polipeptido e2 del virus del papiloma usado para vacunacion.
JP2020521445A5 (https=)
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
JP2003533186A5 (https=)